Selenium

8689 Views
Was this article interesting to you?

Scientific Sources

What was the 1996 JAMA study?

In 1996, Journal of American Medical Association published results of multicenter, randomized, double-blind, placebo-controlled cancer-prevention trial. 1,312 study participants took either 200 mcg selenium daily or placebo over mean period of 4.5 years. Subjects who supplemented had 37% decrease in total cancer incidence, 58% reduction in prostate cancer, 54% reduction in colorectal cancer, and 30% reduction in lung cancer.

What is p53 protein?

Selenium promotes activity of p53 protein, often called "guardian of the genome." Well over half of all cancers exhibit evidence of defective p53 protein. When DNA damaged, p53 either stimulates DNA repair or causes cells to self-destruct (apoptosis) if DNA damage irreparable. Selenium supports this critical cancer defense mechanism.

What forms of selenium exist?

Dietary selenium primarily inorganic selenite or organic selenomethionine. Dietary selenite more than 80% bioavailable, while dietary selenomethionine more than 90% bioavailable. Selenomethionine is major seleno-compound in cereal grains, legumes, soybeans, yeast. Brazil nuts may be richest dietary source.

Which form prevents cancer best?

Selenite has greater capacity than selenomethionine to cause DNA damage, but more effective in preventing cancer. Se-methylselenocysteine, however, not only has less capacity for toxicity, but also may be most effective of selenium compounds for cancer prevention. All selenium compounds must be metabolized to active forms.

Bioavailability differences?

Dietary selenite more than 80% bioavailable. Dietary selenomethionine more than 90% bioavailable. Selenomethionine major form in plant sources like cereal grains, legumes, soybeans, yeast. Brazil nuts particularly rich source. Different forms have different metabolic pathways and cancer-prevention activities.

  • 37% decrease in total cancer incidence 1996 JAMA study, 200 mcg daily
  • 58% reduction in prostate cancer same study
  • 54% reduction in colorectal cancer same study
  • 30% reduction in lung cancer same study
  • 1,312 participants over 4.5 years multicenter randomized controlled trial
  • P53 "guardian of genome" promotion selenium supports critical protein
  • Over half cancers have defective p53 selenium helps maintain function
  • DNA repair or apoptosis stimulation p53 mechanisms supported
  • Selenomethionine 90%+ bioavailable organic form highly absorbable
  • Selenite 80%+ bioavailable inorganic form effective
  • Se-methylselenocysteine most effective for cancer prevention with less toxicity
  • Brazil nuts richest dietary source natural selenium content
  • Cereal grains, legumes, soybeans, yeast contain selenomethionine
  • Different forms different activities each has unique cancer-prevention suite

Selenium Cancer Prevention Protocol

Step 1: Understand 1996 JAMA Landmark Study

Journal of American Medical Association published results of multicenter, randomized, double-blind, placebo-controlled cancer-prevention trial. 1,312 participants took either 200 mcg selenium daily or placebo over mean 4.5 years. Subjects who supplemented had 37% decrease in total cancer incidence, 58% reduction in prostate cancer, 54% reduction in colorectal cancer, 30% reduction in lung cancer.

Step 2: P53 "Guardian of Genome" Support

Selenium promotes activity of p53 protein, often called "guardian of genome." Well over half of all cancers exhibit evidence of defective p53 protein. When DNA damaged, p53 either stimulates DNA repair or causes cells to self-destruct (apoptosis) if DNA damage irreparable. Selenium essential for maintaining this critical defense.

Step 3: Choose Appropriate Selenium Form

Dietary selenium primarily inorganic selenite or organic selenomethionine. Selenite more than 80% bioavailable, selenomethionine more than 90% bioavailable. Se-methylselenocysteine may be most effective for cancer prevention with less toxicity capacity. All forms must be metabolized to active compounds.

Step 4: Dietary Sources vs Supplementation

Selenomethionine major seleno-compound in cereal grains, legumes, soybeans, yeast. Brazil nuts may be richest dietary source. However, achieving 200 mcg daily dose used in studies typically requires supplementation beyond dietary intake.

Step 5: Form-Specific Activities

Selenite has greater capacity than selenomethionine to cause DNA damage, but more effective in preventing cancer. Different forms have unique suite of activities. Se-methylselenocysteine combines effectiveness with lower toxicity profile.

Step 6: 200 mcg Daily Dose

Based on JAMA study showing 37% total cancer reduction, 200 mcg daily represents evidence-based dosing for cancer prevention. This dose safe and effective over 4.5-year study period in 1,312 participants.

  • Cancer prevention (Z80.9 - Family history of malignant neoplasm)
  • Prostate cancer risk (Z80.42 - 58% reduction documented)
  • Colorectal cancer risk (Z80.0 - 54% reduction documented)
  • Lung cancer risk (Z80.1 - 30% reduction documented)
  • Defective p53 protein over half of all cancers
  • DNA damage accumulation requiring repair support
  • Apoptosis dysfunction cells failing to self-destruct when damaged
  • Selenium-deficient diet low cereal grains, legumes, Brazil nuts
  • Geographic areas with low soil selenium
  • Total cancer incidence reduction candidates 37% decrease possible
  • Selenium toxicity history (excess can be harmful)
  • High-dose supplementation>400 mcg daily without monitoring
  • Selenium hypersensitivity
  • Kidney dysfunction without medical supervision

1996 JAMA Cancer Prevention Trial: In 1996, Journal of American Medical Association published results of multicenter, randomized, double-blind, placebo-controlled cancer-prevention trial. 1,312 study participants took either 200 mcg of selenium daily or placebo over mean period of 4.5 years. Subjects who supplemented with selenium had 37% decrease in total cancer incidence, as well as 58% reduction in prostate cancer, 54% reduction in colorectal cancer, and 30% reduction in lung cancer.

P53 "Guardian of Genome" Regulation: Selenium promotes activity of p53 protein, often called "guardian of the genome." Well over half of all cancers exhibit evidence of defective p53 protein. When DNA is damaged, p53 either stimulates DNA repair or causes cells to self-destruct (apoptosis) if DNA damage is irreparable. Selenomethionine regulation of p53 by ref1-dependent redox mechanism documented.

Citation: Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA. 2002 Oct 29;99(22):14548-53.

Nrf-2 Redox Control and Antioxidant Enzymes: Compartmentation of Nrf-2 redox control and regulation of cytoplasmic activities documented. Selenium compounds elevate manganese superoxide dismutase gene expression through redox mechanisms. Hansen compartment regulation and Das elevation studies show selenium's antioxidant enzyme induction.

Citations: Hansen JM, Watson WH, Jones DP. Compartmentation of Nrf-2 redox control. Toxicol Sci. 2004. | Das KC, Lewis-Molock Y, White CW. Elevation of manganese superoxide dismutase gene expression. Am J Respir Cell Mol Biol. 1997.

DNA Methylation and Genetic Effects: Dietary selenium and arsenic affect DNA methylation in vitro. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt foci. Science peels onion of selenium effects on prostate carcinogenesis showing multiple genetic mechanisms.

Citations: Davis CD, Uthus EO, Finley JW. Dietary selenium and arsenic affect DNA methylation in vitro. J Nutr. 2000. | Davis CD, Uthus EO. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt foci. J Nutr. 2003. | Taylor PR, Parnes HL, Lippman SM. Science peels the onion of selenium effects. J Natl Cancer Inst. 2004.

Inflammation and Cancer Connection: Inflammation and cancer relationship well-established. NF-kappaB linking inflammation and immunity to cancer development. Infections as major preventable cause of human cancer. Selenium-containing compounds attenuate peroxynitrite-mediated NF-kappaB activation, breaking inflammation-cancer link.

Citations: Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002. | Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development. Nat Rev Immunol. 2005. | Kuper H, Adami HO, Trichopoulos D. Infections as major preventable cause of human cancer. J Intern Med. 2000. | Jozsef L, Filep JG. Selenium-containing compounds attenuate peroxynitrite-mediated NF-kappaB. Free Radic Biol Med. 2003.

Invasion Inhibition and DNA Protection: Inhibitory effect of selenite on invasion of HT1080 tumor cells documented. Selenium-containing compounds protect DNA from single-strand breaks through antioxidant mechanisms. Multi-level cancer prevention from genetic to cellular invasion stages.

Citations: Yoon SO, Kim MM, Chung AS. Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem. 2001. | Roussyn I, Briviba K, Masumoto H, Sies H. Selenium-containing compounds protect DNA from single-strand breaks. Arch Biochem Biophys. 1996.